Title f-27 LAWS reference
Explore the full hierarchy of this title across chapters, subchapters, and parts.
Select a part from the tree to begin
Browse chapters and parts on the left to load sections
CANADA • Title f-27 Laws • Part 21.71
Part 21.71 — Duty to publicize clinical trial information
This section mandates that holders of therapeutic product authorizations must ensure that prescribed clinical trial information is made public within a specified timeframe and according to a defined manner.
What this part covers
- The holder of a therapeutic product authorization shall ensure that prescribed information concerning the clinical trial is made public.
- The holder shall ensure that the information is made public within the prescribed time.
- The holder shall ensure that the information is made public in the prescribed manner.
Sections in Part 21.71
Regulatory Context
This document sits within CANADA Laws and is most useful when linked to operational submission, quality, and inspection workflows.
CANADALaws